nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—SLC2A1—endothelium—melanoma	0.0385	0.155	CbGeAlD
Etomidate—SLC2A1—hair follicle—melanoma	0.0379	0.152	CbGeAlD
Etomidate—SLC2A1—blood vessel—melanoma	0.0355	0.143	CbGeAlD
Etomidate—SLC2A1—neck—melanoma	0.0254	0.102	CbGeAlD
Etomidate—SLC2A1—eye—melanoma	0.0189	0.0759	CbGeAlD
Etomidate—SLC2A1—retina—melanoma	0.0187	0.0753	CbGeAlD
Etomidate—SLC2A1—skin of body—melanoma	0.0164	0.0661	CbGeAlD
Etomidate—SLC2A1—mammalian vulva—melanoma	0.015	0.0602	CbGeAlD
Etomidate—SLC2A1—head—melanoma	0.0107	0.0431	CbGeAlD
Etomidate—Pseudoephedrine—IL2—melanoma	0.00801	0.352	CrCbGaD
Etomidate—SLC2A1—lymph node—melanoma	0.00752	0.0302	CbGeAlD
Etomidate—Pethidine—GRIN2A—melanoma	0.0075	0.33	CrCbGaD
Etomidate—CYP11B2—lymph node—melanoma	0.00644	0.0258	CbGeAlD
Etomidate—GABRG2—head—melanoma	0.00419	0.0168	CbGeAlD
Etomidate—GABRB2—head—melanoma	0.00419	0.0168	CbGeAlD
Etomidate—GABRA1—head—melanoma	0.0037	0.0148	CbGeAlD
Etomidate—CYP19A1—head—melanoma	0.00339	0.0136	CbGeAlD
Etomidate—Pseudoephedrine—TNF—melanoma	0.0027	0.119	CrCbGaD
Etomidate—CYP19A1—lymph node—melanoma	0.00238	0.00954	CbGeAlD
Etomidate—Fenoprofen—PTGS2—melanoma	0.00176	0.0775	CrCbGaD
Etomidate—Fenoprofen—ALB—melanoma	0.00157	0.0691	CrCbGaD
Etomidate—Pethidine—ALB—melanoma	0.00118	0.0521	CrCbGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—melanoma	0.000164	0.000226	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKR1B10—melanoma	0.000164	0.000225	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—F2R—melanoma	0.000163	0.000224	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ITGB3—melanoma	0.000159	0.000219	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PRKCA—melanoma	0.000159	0.000219	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCB1—melanoma	0.000159	0.000219	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—EDNRB—melanoma	0.000158	0.000217	CbGpPWpGaD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000158	0.000217	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000157	0.000215	CbGpPWpGaD
Etomidate—SLC2A1—Disease—STAT3—melanoma	0.000155	0.000213	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NRAS—melanoma	0.000155	0.000213	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—F2RL1—melanoma	0.000152	0.000209	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GAB2—melanoma	0.000149	0.000205	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GNA11—melanoma	0.000149	0.000205	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—HRAS—melanoma	0.000148	0.000204	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MAPK3—melanoma	0.000148	0.000204	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLA2G6—melanoma	0.000148	0.000203	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—F2R—melanoma	0.000148	0.000203	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—RAC1—melanoma	0.000148	0.000203	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	0.000148	0.000203	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000147	0.000202	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PRKCA—melanoma	0.000147	0.000201	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ERCC2—melanoma	0.000145	0.0002	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTEN—melanoma	0.000145	0.0002	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—melanoma	0.000145	0.000199	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MYC—melanoma	0.000144	0.000198	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EDNRB—melanoma	0.000143	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRM3—melanoma	0.000143	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MMP1—melanoma	0.000143	0.000196	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—MAPK1—melanoma	0.000142	0.000194	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MAPK1—melanoma	0.000141	0.000194	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EGFR—melanoma	0.000141	0.000194	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CDK2—melanoma	0.00014	0.000193	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCR4—melanoma	0.00014	0.000193	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000139	0.000191	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GNAQ—melanoma	0.000139	0.00019	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	0.000139	0.00019	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCB1—melanoma	0.000137	0.000189	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—MAPK3—melanoma	0.000137	0.000188	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KISS1—melanoma	0.000136	0.000186	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	0.000136	0.000186	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GAB2—melanoma	0.000135	0.000186	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNA11—melanoma	0.000135	0.000186	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000135	0.000185	CbGpPWpGaD
Etomidate—SLC2A1—Disease—KRAS—melanoma	0.000133	0.000183	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—VCAN—melanoma	0.000133	0.000183	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SKI—melanoma	0.000131	0.000181	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCR1—melanoma	0.000131	0.000181	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—FN1—melanoma	0.00013	0.000179	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—melanoma	0.00013	0.000179	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—MAPK1—melanoma	0.00013	0.000178	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MC1R—melanoma	0.00013	0.000178	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS2—melanoma	0.000129	0.000177	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT3—melanoma	0.000128	0.000176	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCR4—melanoma	0.000127	0.000175	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PRKCA—melanoma	0.000126	0.000173	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GNAQ—melanoma	0.000126	0.000173	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000126	0.000173	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ERCC2—melanoma	0.000125	0.000172	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CG—melanoma	0.000125	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR7—melanoma	0.000124	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRM1—melanoma	0.000124	0.000171	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EGF—melanoma	0.000123	0.000169	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ALB—melanoma	0.000123	0.000169	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PIK3CA—melanoma	0.000122	0.000168	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000122	0.000167	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SUFU—melanoma	0.000121	0.000166	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.00012	0.000165	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	0.000119	0.000163	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT3—melanoma	0.000116	0.00016	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CG—melanoma	0.000115	0.000158	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF1—melanoma	0.000114	0.000157	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—HRAS—melanoma	0.000114	0.000156	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HRAS—melanoma	0.000113	0.000156	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—MAPK1—melanoma	0.000113	0.000155	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PIK3CA—melanoma	0.000113	0.000155	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BCL2L11—melanoma	0.000113	0.000155	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RHOB—melanoma	0.000113	0.000155	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	0.000112	0.000154	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP17A1—melanoma	0.000112	0.000154	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARG—melanoma	0.000111	0.000152	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000111	0.000152	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CD—melanoma	0.00011	0.000151	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000109	0.00015	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HDAC6—melanoma	0.000109	0.000149	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6—melanoma	0.000108	0.000149	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ALB—melanoma	0.000108	0.000149	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—EDN1—melanoma	0.000108	0.000148	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNA11—melanoma	0.000106	0.000146	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CSF2—melanoma	0.000105	0.000144	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—HRAS—melanoma	0.000104	0.000143	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000104	0.000143	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—FASN—melanoma	0.000104	0.000142	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCR2—melanoma	0.000103	0.000141	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL8—melanoma	0.000103	0.000141	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PIK3CA—melanoma	0.000103	0.000141	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC5A5—melanoma	0.000102	0.00014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RAC2—melanoma	0.000101	0.000139	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CD—melanoma	0.000101	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCA—melanoma	0.000101	0.000138	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—melanoma	0.0001	0.000137	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALB—melanoma	9.97e-05	0.000137	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—WNT5A—melanoma	9.97e-05	0.000137	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFC—melanoma	9.97e-05	0.000137	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CG—melanoma	9.9e-05	0.000136	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GNAQ—melanoma	9.85e-05	0.000135	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CD44—melanoma	9.85e-05	0.000135	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	9.81e-05	0.000135	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EDN1—melanoma	9.76e-05	0.000134	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.65e-05	0.000132	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CB—melanoma	9.57e-05	0.000131	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.56e-05	0.000131	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARG—melanoma	9.55e-05	0.000131	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CSF2—melanoma	9.54e-05	0.000131	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP1B1—melanoma	9.45e-05	0.00013	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—RAC1—melanoma	9.34e-05	0.000128	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—melanoma	9.24e-05	0.000127	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCA—melanoma	9.15e-05	0.000126	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—HRAS—melanoma	9.09e-05	0.000125	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MAP2K2—melanoma	8.94e-05	0.000123	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CB—melanoma	8.8e-05	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2—melanoma	8.79e-05	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—F2R—melanoma	8.75e-05	0.00012	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—melanoma	8.72e-05	0.00012	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CD—melanoma	8.7e-05	0.000119	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALB—melanoma	8.59e-05	0.000118	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—RAC1—melanoma	8.48e-05	0.000116	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDNRB—melanoma	8.47e-05	0.000116	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—melanoma	8.38e-05	0.000115	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.34e-05	0.000114	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTK2B—melanoma	8.23e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GAB2—melanoma	8e-05	0.00011	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNA11—melanoma	8e-05	0.00011	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FLT1—melanoma	7.97e-05	0.000109	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CG—melanoma	7.89e-05	0.000108	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCB1—melanoma	7.78e-05	0.000107	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTEN—melanoma	7.6e-05	0.000104	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CB—melanoma	7.58e-05	0.000104	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HDAC2—melanoma	7.52e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCR4—melanoma	7.52e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FOXO4—melanoma	7.52e-05	0.000103	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—melanoma	7.51e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—melanoma	7.47e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GNAQ—melanoma	7.44e-05	0.000102	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NRAS—melanoma	7.38e-05	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CG—melanoma	7.17e-05	9.84e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PRKCA—melanoma	7.16e-05	9.83e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ERCC2—melanoma	7.1e-05	9.75e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MAPK3—melanoma	7.07e-05	9.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SYK—melanoma	6.99e-05	9.6e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CD—melanoma	6.94e-05	9.53e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ITGAV—melanoma	6.87e-05	9.43e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGFR—melanoma	6.87e-05	9.43e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT3—melanoma	6.87e-05	9.43e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MAPK1—melanoma	6.72e-05	9.23e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTEN—melanoma	6.55e-05	9e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SOCS1—melanoma	6.36e-05	8.73e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—KRAS—melanoma	6.35e-05	8.72e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MAP2K1—melanoma	6.34e-05	8.71e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—S100B—melanoma	6.34e-05	8.71e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CD—melanoma	6.3e-05	8.65e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB4—melanoma	6.06e-05	8.33e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CB—melanoma	6.05e-05	8.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN2B—melanoma	6.01e-05	8.25e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.88e-05	8.08e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PIK3CA—melanoma	5.83e-05	8.01e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CD86—melanoma	5.81e-05	7.98e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL8—melanoma	5.81e-05	7.98e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EDN1—melanoma	5.77e-05	7.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—melanoma	5.64e-05	7.75e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGF1—melanoma	5.64e-05	7.74e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CSF2—melanoma	5.64e-05	7.74e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CG—melanoma	5.61e-05	7.7e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2—melanoma	5.55e-05	7.63e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—E2F1—melanoma	5.52e-05	7.58e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CB—melanoma	5.49e-05	7.54e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDGFRA—melanoma	5.46e-05	7.5e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARG—melanoma	5.41e-05	7.43e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ITGB3—melanoma	5.41e-05	7.42e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCA—melanoma	5.41e-05	7.42e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—HRAS—melanoma	5.4e-05	7.41e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3CA—melanoma	5.36e-05	7.37e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SPP1—melanoma	5.3e-05	7.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAP2K2—melanoma	5.28e-05	7.26e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL8—melanoma	5.28e-05	7.25e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2—melanoma	5.04e-05	6.92e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TERT—melanoma	5.02e-05	6.9e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RAC1—melanoma	5.01e-05	6.88e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CD—melanoma	4.93e-05	6.77e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALB—melanoma	4.87e-05	6.68e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HIF1A—melanoma	4.81e-05	6.6e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—melanoma	4.77e-05	6.54e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3CA—melanoma	4.62e-05	6.35e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KDR—melanoma	4.6e-05	6.31e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FN1—melanoma	4.42e-05	6.07e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—melanoma	4.38e-05	6.02e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH1—melanoma	4.33e-05	5.94e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CB—melanoma	4.3e-05	5.9e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—melanoma	4.26e-05	5.85e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CD80—melanoma	4.24e-05	5.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APC—melanoma	4.23e-05	5.81e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CG—melanoma	4.23e-05	5.81e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KIT—melanoma	4.23e-05	5.81e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NRAS—melanoma	4.23e-05	5.81e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGF—melanoma	4.18e-05	5.75e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MAPK3—melanoma	4.05e-05	5.57e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—BRAF—melanoma	3.98e-05	5.46e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—melanoma	3.88e-05	5.32e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MAPK1—melanoma	3.86e-05	5.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—EGFR—melanoma	3.86e-05	5.3e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—melanoma	3.78e-05	5.19e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAP2K1—melanoma	3.75e-05	5.14e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CD—melanoma	3.72e-05	5.11e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTEN—melanoma	3.71e-05	5.1e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PIK3CA—melanoma	3.69e-05	5.06e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—KRAS—melanoma	3.64e-05	5e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGF2—melanoma	3.56e-05	4.89e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PIK3CA—melanoma	3.35e-05	4.6e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MDM2—melanoma	3.33e-05	4.58e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB2—melanoma	3.29e-05	4.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CB—melanoma	3.24e-05	4.45e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL8—melanoma	3.12e-05	4.28e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HRAS—melanoma	3.1e-05	4.25e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1B—melanoma	3.04e-05	4.18e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—melanoma	3.01e-05	4.14e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP3—melanoma	2.98e-05	4.1e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2—melanoma	2.98e-05	4.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—melanoma	2.96e-05	4.07e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCND1—melanoma	2.9e-05	3.99e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CTNNB1—melanoma	2.88e-05	3.95e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—melanoma	2.82e-05	3.87e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDKN1A—melanoma	2.81e-05	3.86e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTEN—melanoma	2.8e-05	3.85e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NFKB1—melanoma	2.79e-05	3.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—melanoma	2.73e-05	3.76e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3CA—melanoma	2.62e-05	3.6e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—melanoma	2.53e-05	3.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STAT3—melanoma	2.51e-05	3.44e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NRAS—melanoma	2.5e-05	3.43e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK3—melanoma	2.4e-05	3.29e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—melanoma	2.33e-05	3.2e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK1—melanoma	2.28e-05	3.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EGFR—melanoma	2.28e-05	3.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—KRAS—melanoma	2.15e-05	2.96e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—melanoma	2.14e-05	2.94e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PIK3CA—melanoma	1.98e-05	2.72e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—melanoma	1.91e-05	2.63e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HRAS—melanoma	1.83e-05	2.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—melanoma	1.75e-05	2.4e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—melanoma	1.62e-05	2.22e-05	CbGpPWpGaD
